Gene amplification and protein overexpression of FGFR1 was detected in squamous cell lung carcinoma (~20%), small-cell lung carcinoma (6%) and breast cancers (10–13%), including hormone receptor-positive or triple-negative breast cancers [46,47,48]. This evidence concerns the gene FGFR1 and breast carcinoma.